Role of IL-21 in immune-regulation and tumor immunotherapy Emma di CarloDaniela de ToteroSilvano Ferrini Review 20 April 2007 Pages: 1323 - 1334
Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor Karin TegerstedtAndrea FranzénTina Dalianis Original Article 01 February 2007 Pages: 1335 - 1344
The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs Peter RavnRenate StahnSteffen Goletz Original Article 20 February 2007 Pages: 1345 - 1357
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33 Satoko MatsuedaAkira YamadaKyogo Itoh Original Article 31 January 2007 Pages: 1359 - 1366
Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity Joanne LysaghtAndrew G. JarnickiKingston H. G. Mills Original Article 06 February 2007 Pages: 1367 - 1379
Development of anti-PAX3 immune responses; a target for cancer immunotherapy Nourredine HimoudiSteven NabarroJohn Anderson Original Article 23 February 2007 Pages: 1381 - 1395
Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial Herbert RiechelmannMarkus WiesnethMichael Schmitt Original Article 02 February 2007 Pages: 1397 - 1406
Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma Nicolae-Costin DiaconuRenata KaminskaIlkka T. Harvima Original Article 01 February 2007 Pages: 1407 - 1415
Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors Henrik SøndergaardKlaus S. FrederiksenMichael Kragh Original Article 07 February 2007 Pages: 1417 - 1428
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment Christoph BergmannLaura StraussTheresa L. Whiteside Original Article 31 January 2007 Pages: 1429 - 1442
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery Aleksandra KowalczykAndrzej WierzbickiDanuta Kozbor Original Article 14 February 2007 Pages: 1443 - 1458
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor Andrea LadányiJudit KissJózsef Tímár Original Article 06 February 2007 Pages: 1459 - 1469
The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses Mala ChakrabortyJeffrey SchlomJames W. Hodge Original Article 23 February 2007 Pages: 1471 - 1484
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers Inge Marie SvaneAnders E. PedersenMogens H. Claesson Original Article 07 February 2007 Pages: 1485 - 1499
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies Janet W. de BeukelaarGeorges M. VerjansPeter A. Sillevis Smitt Original Article Open access 14 February 2007 Pages: 1501 - 1506
Long-term immunity elicited by antibody–cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies Gustavo HelgueraJosé A. RodríguezManuel L. Penichet Short Communication 20 February 2007 Pages: 1507 - 1512
